resource logo

SWISS-2DPAGE

Attention: World-2DPAGE is no longer maintained.


SWISS-2DPAGE 
Search by  [accession number] *
[description, ID or gene] 
[author names] 
[spot ID / serial number] 
[identification methods] 
[pI / Mw range] 
[combined fields] 

Maps  [experimental info] 
[protein list] 
[graphical interface]

     Select Remote Interfaces
[All Interfaces]
World-2DPAGE Portal
World-2DPAGE Repository

Exclude local DBs
has only effect if a remote
interface is selected
     

Sample Preparation and Post-separation Analysis



Searching in 'SWISS-2DPAGE' for entry matching: P0A6P1




SWISS-2DPAGE: P0A6P1



P0A6P1:

Nice View - a user-friendly view of this entry
ID   EFTS_ECOLI; STANDARD; 2DG.
AC   P0A6P1; P02997;
DT   01-AUG-1995, integrated into SWISS-2DPAGE (release 2).
DT   31-MAR-2004, 2D annotation version 6.
DT   19-MAY-2011, general annotation version 15.
DE   RecName: Full=Elongation factor Ts; Short=EF-Ts;.
GN   Name=tsf; OrderedLocusNames=b0170, JW0165;
OS   Escherichia coli.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
MT   ECOLI, ECOLI4.5-5.5, ECOLI-DIGE4.5-6.5.
IM   ECOLI, ECOLI4.5-5.5, ECOLI-DIGE4.5-6.5.
RN   [1]
RP   MAPPING ON GEL.
RX   MEDLINE=96314059; PubMed=8740179; [NCBI, Expasy, EBI, Israel, Japan]
RA   Pasquali C., Frutiger S., Wilkins M.R., Hughes G.J., Appel R.D., Bairoch
RA   A., Schaller D., Sanchez J.-C., Hochstrasser D.F.;
RT   ''''''Two-dimensional gel electrophoresis of Escherichia coli
RT   homogenates: the Escherichia coli SWISS-2DPAGE database'';'';'';
RL   Electrophoresis 17(1):547-555(1996).
RN   [2]
RP   MAPPING ON GEL.
RA   Vanbogelen R.A., Abshire K.Z., Pertsemlidis A., Clark R.L., Neidhardt F.C.;
RT   ''''''Gene-protein database of Escherichia coli K-12, edition 6'';'';'';
RL   (IN) Neidhardt et al. (eds.);
RL   Escherichia coli and Salmonella: Cellular and Molecular Biology (2nd
RL   ed.), pp.2067-2117, ASM Press, Washington DC (1996).
RN   [3]
RP   MAPPING ON GEL.
RX   MEDLINE=80159887; PubMed=6988414; [NCBI, Expasy, EBI, Israel, Japan]
RA   Bloch P.L., Phillips T.A., Neidhardt F.C.;
RT   ''''''Protein identifications of O'Farrell two-dimensional gels:
RT   locations of 81 Escherichia coli proteins'';'';'';
RL   J. Bacteriol. 141(1):1409-1420(1980).
RN   [4]
RP   MAPPING ON GEL.
RX   MEDLINE=98410772; PubMed=9740056; [NCBI, Expasy, EBI, Israel, Japan]
RA   Tonella L., Walsh B.J., Sanchez J.-C., Ou K., Wilkins M.R., Tyler M.,
RA   Frutiger S., Gooley A.A., Pescaru I., Appel R.D., Yan J.X., Bairoch A.,
RA   Hoogland C., Morch F.S., Hughes G.J., Williams K.L., Hochstrasser D.F.;
RT   '''''''98 Escherichia coli SWISS-2DPAGE database update'';'';'';
RL   Electrophoresis 19(1):1960-1971(1998).
RN   [5]
RP   PROTEIN EXPRESSION.
RX   MEDLINE=79216190; PubMed=156716; [NCBI, Expasy, EBI, Israel, Japan]
RA   Herendeen S.L., Vanbogelen R.A., Neidhardt F.C.;
RT   ''''''Levels of major proteins of Escherichia coli during growth at
RT   different temperatures'';'';'';
RL   J. Bacteriol. 139(1):185-194(1979).
RN   [6]
RP   PROTEIN EXPRESSION.
RX   MEDLINE=78212912; PubMed=352533; [NCBI, Expasy, EBI, Israel, Japan]
RA   Pedersen S., Bloch P.L., Reeh S., Neidhardt F.C.;
RT   ''''''Patterns of protein synthesis in E. coli: a catalog of the amount
RT   of 140 individual proteins at different growth rates'';'';'';
RL   Cell 14(1):179-190(1978).
RN   [7]
RP   MAPPING ON GEL.
RX   PubMed=11680886; [NCBI, Expasy, EBI, Israel, Japan]
RA   Tonella L., Hoogland C., Binz P.-A., Appel R.D., Hochstrasser D.F.,
RA   Sanchez J.-C.;
RT   ''''''New perspectives in the Escherichia coli proteome investigation'';'';'';
RL   Proteomics 1(1):409-423(2001).
RN   [8]
RP   MAPPING ON GEL.
RX   PubMed=12469338; [NCBI, Expasy, EBI, Israel, Japan]
RA   Yan J.X., Devenish A.T., Wait R., Stone T., Lewis S., Fowler S.;
RT   ''''''Fluorescence 2-D difference gel electrophoresis and mass
RT   spectrometry based proteomic analysis of E. coli'';'';'';
RL   Proteomics 2(1):1682-1698(2002).
2D   -!- MASTER: ECOLI;
2D   -!-   PI/MW: SPOT 2D-000L7K=5.16/33686;
2D   -!-   PI/MW: SPOT 2D-000L7M=5.06/33758;
2D   -!-   AMINO ACID COMPOSITION: SPOT 2D-000L7M: B=8.4, Z=11.9, S=4.5,
2D         H=1.3, G=9.6, T=4.4, A=12.8, P=2.8, Y=1.7, R=4.3, V=9.9, M=2.6, I=6.5,
2D         L=7.5, F=4.7, K=7.3;
2D   -!-   EXPRESSION: CHANGED VERY LITTLE THROUGHOUT THE NORMAL ARRHENIUS
2D         RANGE (23 TO 37°C) [5]; INCREASED IN LEVEL WITH INCREASING GROWTH RATE [6].
2D   -!-   MAPPING: SPOT 2D-000L7K: AMINO ACID COMPOSITION AND MICROSEQUENCE
2D         ANALYSIS [1] AND IDENTIFIED ON 2-D GELS BY VANBOGELEN [2] AND BLOCH [3];
2D         SPOT 2D-000L7M: AMINO ACID COMPOSITION AND SEQUENCE TAG (AE) [4].
2D   -!- MASTER: ECOLI4.5-5.5;
2D   -!-   PI/MW: SPOT 2D-00156V=5.22/32533;
2D   -!-   PEPTIDE MASSES: SPOT 2D-00156V: 908.22; 928.33; 1069.27; 1272.38;
2D         1742.56; 1875.56; TRYPSIN.
2D   -!-   MAPPING: Peptide mass fingerprinting [7].
2D   -!- MASTER: ECOLI-DIGE4.5-6.5;
2D   -!-   PI/MW: SPOT 2D-001WPB=5.14/34596;
2D   -!-   PI/MW: SPOT 2D-001WPF=5.08/34633;
2D   -!-   PI/MW: SPOT 2D-001WPG=5.20/34415;
2D   -!-   PEPTIDE MASSES: SPOT 2D-001WPB: 908.34; 928.47; 1069.4; 1084.53;
2D         1272.52; 1742.73; 1898.8; 2268.91; TRYPSIN.
2D   -!-   PEPTIDE MASSES: SPOT 2D-001WPG: 860.39; 908.33; 916.45; 928.47;
2D         1007.41; 1014.47; 1069.39; 1084.53; 1142.55; 1272.53; 1742.74; 1859.75;
2D         1893.79; 1898.81; 1987.82; TRYPSIN.
2D   -!-   PEPTIDE SEQUENCES: SPOT 2D-001WPB: (K)AQFEEER(V),112-118.
2D   -!-   PEPTIDE SEQUENCES: SPOT 2D-001WPF: (K)DAGFQAFADKVLDAAVAGK(I),85-103.
2D   -!-   PEPTIDE SEQUENCES: SPOT 2D-001WPG: (K)DAGFQAFADK(V),85-94;
2D         (K)AQFEEER(V),112-118; (K)IGENINIR(R),125-132.
2D   -!-   EXPRESSION: increase after benzoic acid treatment [8].
2D   -!-   MAPPING: SPOTS 1WPB, 1WPG: PEPTIDE MASS FINGERPRINTING [8]; Tandem
2D         mass spectrometry [8].
CC   ---------------------------------------------------------------------------
CC   This SWISS-2DPAGE entry is copyright the Swiss Institute of Bioinformatics.
CC   There are no restrictions on its use by non-profit institutions as long as
CC   its content is in no way modified and this statement is not removed.
CC   Usage by and for commercial entities requires a license agreement (See
CC   http://world-2dpage.expasy.org/swiss-2dpage/docs/license.html or send email from legal@sib.swiss).
CC   ---------------------------------------------------------------------------
DR   2DBase-Ecoli; P0A6P1; EFTS_ECOLI.
DR   ECO2DBASE; C030.7; 6TH EDITION.
DR   ECO2DBASE; C031.6; 6TH EDITION.
DR   UniProtKB/Swiss-Prot; P0A6P1; EFTS_ECOLI.
//


The following 2-D maps are available for this protein:
Escherichia coli
ECOLI
Escherichia coli(4.5-5.5)
ECOLI4.5-5.5
Escherichia coli DIGE (4.5-6.5)
ECOLI-DIGE4.5-6.5


SWISS-2DPAGE image

SWISS-2DPAGE (search AC)


Database constructed and maintained by SIB, using the Make2D-DB II package (ver. 3.10.2) from the World-2DPAGE Constellation of the Expasy web server